Endocrinol Metab.  2021 Apr;36(2):240-255. 10.3803/EnM.2021.201.

Continuous Glucose Monitoring in the Hospital

Affiliations
  • 1Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University, Atlanta, GA, USA
  • 2Diabetes Technology Society, Burlingame, CA, USA
  • 3Diabetes Program, Mills-Peninsula Medical Center, Burlingame, CA, USA
  • 4Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, USA

Abstract

Continuous glucose monitors (CGMs) have suddenly become part of routine care in many hospitals. The coronavirus disease 2019 (COVID-19) pandemic has necessitated the use of new technologies and new processes to care for hospitalized patients, including diabetes patients. The use of CGMs to automatically and remotely supplement or replace assisted monitoring of blood glucose by bedside nurses can decrease: the amount of necessary nursing exposure to COVID-19 patients with diabetes; the amount of time required for obtaining blood glucose measurements, and the amount of personal protective equipment necessary for interacting with patients during the blood glucose testing. The United States Food and Drug Administration (FDA) is now exercising enforcement discretion and not objecting to certain factory-calibrated CGMs being used in a hospital setting, both to facilitate patient care and to obtain performance data that can be used for future regulatory submissions. CGMs can be used in the hospital to decrease the frequency of fingerstick point of care capillary blood glucose testing, decrease hyperglycemic episodes, and decrease hypoglycemic episodes. Most of the research on CGMs in the hospital has focused on their accuracy and only recently outcomes data has been reported. A hospital CGM program requires cooperation of physicians, bedside nurses, diabetes educators, and hospital administrators to appropriately select and manage patients. Processes for collecting, reviewing, storing, and responding to CGM data must be established for such a program to be successful. CGM technology is advancing and we expect that CGMs will be increasingly used in the hospital for patients with diabetes.

Keyword

Blood glucose; COVID-19; Diabetes mellitus; Glucose; Hospitals; Intensive care units; Technology

Reference

1. Galindo RJ, Aleppo G. Continuous glucose monitoring: the achievement of 100 years of innovation in diabetes technology. Diabetes Res Clin Pract. 2020; 170:108502.
2. Acciaroli G, Vettoretti M, Facchinetti A, Sparacino G. Calibration of minimally invasive continuous glucose monitoring sensors: state-of-the-art and current perspectives. Biosensors (Basel). 2018; 8:24.
Article
3. Kovatchev BP, Patek SD, Ortiz EA, Breton MD. Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring. Diabetes Technol Ther. 2015; 17:177–86.
Article
4. Abbott. The FreeStyle Libre 14 day system [Internet]. Chicago: Abbott;2021. [cited 2021 Feb 24]. Available from: https://www.freestyle.abbott/us-en/products/freestyle-14-day.html .
5. Abbott. FreeStyle Libre 2 [Internet]. Chicago: Abbott;2021. [cited 2021 Feb 24]. Available from: https://www.freestyle.abbott/us-en/products/freestyle-libre-2.html .
6. Dexcom. Dexcom G6 CGM System [Internet]. San Diego: Dexcom;2021. [cited 2021 Feb 24]. Available from: https://www.dexcom.com/g6-cgm-system .
7. Galindo RJ, Aleppo G, Klonoff DC, Spanakis EK, Agarwal S, Vellanki P, et al. Implementation of continuous glucose monitoring in the hospital: emergent considerations for remote glucose monitoring during the COVID-19 pandemic. J Diabetes Sci Technol. 2020; 14:822–32.
Article
8. Abbott. FreeStyle Libre flash glucose monitoring system: user’s manual 2016 [Internet]. Chicago: Abbott;2016. [cited 2021 Feb 24]. Available from: https://freestyleserver.com/Payloads/IFU/2017_dec/ART34745-107_rev-A-WEB.pdf .
9. Abbott. FreeStyle Libre: Apps [Internet]. Chicago: Abbott;2021. [cited 2021 Feb 24]. Available from: https://www.freestyle.abbott/us-en/products/continous-glucose-monitor-app.html .
10. Abbott. FreeStyle Libre 2 flash glucose monitoring system: user’s manual 2020 [Internet]. Chicago: Abbott;2020. [cited 2021 Feb 24]. Available from: https://freestyleserver.com/Payloads/IFU/2020/q2/ART40703-001_rev-D-Web.pdf .
11. Alva S, Bailey T, Brazg R, Budiman ES, Castorino K, Christiansen MP, et al. Accuracy of a 14-day factory-calibrated continuous glucose monitoring system with advanced algorithm in pediatric and adult population with diabetes. J Diabetes Sci Technol. 2020. Sep. 19. [Epub]. https://doi.org/10.1177/1932296820958754 .
Article
12. Calhoun P, Johnson TK, Hughes J, Price D, Balo AK. Resistance to acetaminophen interference in a novel continuous glucose monitoring system. J Diabetes Sci Technol. 2018; 12:393–6.
Article
13. Dexcom. Dexcom G6 continuous glucose monitoring system: user guide 2020 [Internet]. San Diego: Dexcom;2020. [cited 2021 Feb 24]. Available from: https://s3-us-west-2.amazonaws.com/dexcompdf/G6-CGM-Users-Guide.pdf .
14. Dexcom. Dexcom: Apps [Internet]. San Diego: Dexcom;2021. [cited 2021 Feb 24]. Available from: https://www.dexcom.com/apps .
15. Freckmann G, Pleus S, Schauer S, Link M, Jendrike N, Waldenmaier D, et al. Choice of continuous glucose monitoring systems may affect metrics: clinically relevant differences in times in ranges. Exp Clin Endocrinol Diabetes. 2021. Jan. 28. [Epub]. https://doi.org/10.1055/a-1347-2550 .
Article
16. Klonoff DC, Ahn D, Drincic A. Continuous glucose monitoring: a review of the technology and clinical use. Diabetes Res Clin Pract. 2017; 133:178–92.
Article
17. Dexcom. Information request for healthcare providers: use of Dexcom continuous glucose monitoring systems during the COVID-19 pandemic [Internet]. San Diego: Dexcom;2021. [cited 2021 Feb 24]. Available from: https://www.dexcom.com/hospitalcovid-19 .
18. Dexcom. Fact sheet for healthcare providers: use of Dexcom continuous glucose monitoring systems during the COVID-19 pandemic [Internet]. San Diego: Dexcom;2021. [cited 2021 Feb 24]. Available from: https://www.dexcom.com/hospitalfacts .
19. Abbott. Abbott’s FreeStyle® Libre 14 day system now available in U.S. for hospitalized patients with diabetes during COVID-19 pandemic [Internet]. Chicago: Abbott;2021. [cited 2021 Feb 24]. Available from: https://abbott.mediaroom.com/2020-04-08-Abbotts-FreeStyle-R-Libre-14-Day-System-Now-Available-in-U-S-for-Hospitalized-Patients-with-Diabetes-During-COVID-19-Pandemic .
20. Yeh T, Yeung M, Mendelsohn Curanaj FA. Managing patients with insulin pumps and continuous glucose monitors in the hospital: to wear or not to wear. Curr Diab Rep. 2021; 21:7.
Article
21. Galindo RJ, Umpierrez GE, Rushakoff RJ, Basu A, Lohnes S, Nichols JH, et al. Continuous glucose monitors and automated insulin dosing systems in the hospital consensus guideline. J Diabetes Sci Technol. 2020; 14:1035–64.
Article
22. Pasquel FJ, Lansang MC, Dhatariya K, Umpierrez GE. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol. 2021; 9:174–88.
Article
23. Klonoff DC, Perz JF. Assisted monitoring of blood glucose: special safety needs for a new paradigm in testing glucose. J Diabetes Sci Technol. 2010; 4:1027–31.
Article
24. Davis GM, Faulds E, Walker T, Vigliotti D, Rabinovich M, Hester J, et al. Remote continuous glucose monitoring with a computerized insulin infusion protocol for critically Ill patients in a COVID-19 medical ICU: proof of concept. Diabetes Care. 2021; 44:1055–8.
Article
25. Baysal N, Cameron F, Buckingham BA, Wilson DM, Chase HP, Maahs DM, et al. A novel method to detect pressure-induced sensor attenuations (PISA) in an artificial pancreas. J Diabetes Sci Technol. 2014; 8:1091–6.
Article
26. Perez-Guzman MC, Duggan E, Gibanica S, Cardona S, Corujo-Rodriguez A, Faloye A, et al. Continuous glucose monitoring in the operating room and cardiac intensive care unit. Diabetes Care. 2021; 44:e50–2.
Article
27. Agarwal S, Mathew J, Davis GM, Shephardson A, Levine A, Louard R, et al. Continuous glucose monitoring in the intensive care unit during the COVID-19 pandemic. Diabetes Care. 2021; 44:847–9.
Article
28. Chow KW, Kelly DJ, Rieff MC, Skala PA, Kravets I, Charitou MM, et al. Outcomes and healthcare provider perceptions of real-time continuous glucose monitoring (rtCGM) in patients with diabetes and COVID-19 admitted to the ICU. J Diabetes Sci Technol. 2021. Jan. 12. [Epub]. https://doi.org/10.1177/1932296820985263 .
Article
29. Sadhu AR, Serrano IA, Xu J, Nisar T, Lucier J, Pandya AR, et al. Continuous glucose monitoring in critically Ill patients with COVID-19: results of an emergent pilot study. J Diabetes Sci Technol. 2020; 14:1065–73.
Article
30. Goldberg PA, Siegel MD, Russell RR, Sherwin RS, Halickman JI, Cooper DA, et al. Experience with the continuous glucose monitoring system in a medical intensive care unit. Diabetes Technol Ther. 2004; 6:339–47.
Article
31. Vriesendorp TM, DeVries JH, Holleman F, Dzoljic M, Hoekstra JB. The use of two continuous glucose sensors during and after surgery. Diabetes Technol Ther. 2005; 7:315–22.
Article
32. Corstjens AM, Ligtenberg JJ, van der Horst IC, Spanjersberg R, Lind JS, Tulleken JE, et al. Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients. Crit Care. 2006; 10:R135.
33. De Block C, Manuel-Y-Keenoy B, Van Gaal L, Rogiers P. Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring. Diabetes Care. 2006; 29:1750–6.
Article
34. Price GC, Stevenson K, Walsh TS. Evaluation of a continuous glucose monitor in an unselected general intensive care population. Crit Care Resusc. 2008; 10:209–16.
35. Logtenberg SJ, Kleefstra N, Snellen FT, Groenier KH, Slingerland RJ, Nierich AP, et al. Pre- and postoperative accuracy and safety of a real-time continuous glucose monitoring system in cardiac surgical patients: a randomized pilot study. Diabetes Technol Ther. 2009; 11:31–7.
Article
36. Yamashita K, Okabayashi T, Yokoyama T, Yatabe T, Maeda H, Manabe M, et al. Accuracy and reliability of continuous blood glucose monitor in post-surgical patients. Acta Anaesthesiol Scand. 2009; 53:66–71.
Article
37. Rabiee A, Andreasik V, Abu-Hamdah R, Galiatsatos P, Khouri Z, Gibson BR, et al. Numerical and clinical accuracy of a continuous glucose monitoring system during intravenous insulin therapy in the surgical and burn intensive care units. J Diabetes Sci Technol. 2009; 3:951–9.
Article
38. Holzinger U, Warszawska J, Kitzberger R, Herkner H, Metnitz PG, Madl C. Impact of shock requiring norepinephrine on the accuracy and reliability of subcutaneous continuous glucose monitoring. Intensive Care Med. 2009; 35:1383–9.
Article
39. Holzinger U, Warszawska J, Kitzberger R, Wewalka M, Miehsler W, Herkner H, et al. Real-time continuous glucose monitoring in critically ill patients: a prospective randomized trial. Diabetes Care. 2010; 33:467–72.
40. Jacobs B, Phan K, Bertheau L, Dogbey G, Schwartz F, Shubrook J. Continuous glucose monitoring system in a rural intensive care unit: a pilot study evaluating accuracy and acceptance. J Diabetes Sci Technol. 2010; 4:636–44.
Article
41. Brunner R, Kitzberger R, Miehsler W, Herkner H, Madl C, Holzinger U. Accuracy and reliability of a subcutaneous continuous glucose-monitoring system in critically ill patients. Crit Care Med. 2011; 39:659–64.
Article
42. Kalmovich B, Bar-Dayan Y, Boaz M, Wainstein J. Continuous glucose monitoring in patients undergoing cardiac surgery. Diabetes Technol Ther. 2012; 14:232–8.
Article
43. Lorencio C, Leal Y, Bonet A, Bondia J, Palerm CC, Tache A, et al. Real-time continuous glucose monitoring in an intensive care unit: better accuracy in patients with septic shock. Diabetes Technol Ther. 2012; 14:568–75.
Article
44. Kopecky P, Mraz M, Blaha J, Lindner J, Svacina S, Hovorka R, et al. The use of continuous glucose monitoring combined with computer-based eMPC algorithm for tight glucose control in cardiosurgical ICU. Biomed Res Int. 2013; 2013:186439.
45. Leelarathna L, English SW, Thabit H, Caldwell K, Allen JM, Kumareswaran K, et al. Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial. Crit Care. 2013; 17:R159.
Article
46. Rodriguez-Quintanilla KA, Lavalle-Gonzalez FJ, Mancillas-Adame LG, Zapata-Garrido AJ, Villarreal-Perez JZ, Tamez-Perez HE. Continuous glucose monitoring in acute coronary syndrome. Arch Cardiol Mex. 2013; 83:237–43.
Article
47. Schuster KM, Barre K, Inzucchi SE, Udelsman R, Davis KA. Continuous glucose monitoring in the surgical intensive care unit: concordance with capillary glucose. J Trauma Acute Care Surg. 2014; 76:798–803.
48. Kosiborod M, Gottlieb RK, Sekella JA, Peterman D, Grodzinsky A, Kennedy P, et al. Performance of the Medtronic Sentrino continuous glucose management (CGM) system in the cardiac intensive care unit. BMJ Open Diabetes Res Care. 2014; 2:e000037.
Article
49. Boom DT, Sechterberger MK, Rijkenberg S, Kreder S, Bosman RJ, Wester JP, et al. Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: a randomized controlled trial. Crit Care. 2014; 18:453.
Article
50. Umbrello M, Salice V, Spanu P, Formenti P, Barassi A, Melzi d’Eril GV, et al. Performance assessment of a glucose control protocol in septic patients with an automated intermittent plasma glucose monitoring device. Clin Nutr. 2014; 33:867–71.
Article
51. van Hooijdonk RT, Leopold JH, Winters T, Binnekade JM, Juffermans NP, Horn J, et al. Point accuracy and reliability of an interstitial continuous glucose-monitoring device in critically ill patients: a prospective study. Crit Care. 2015; 19:34.
Article
52. Sechterberger MK, van der Voort PH, Strasma PJ, DeVries JH. Accuracy of intra-arterial and subcutaneous continuous glucose monitoring in postoperative cardiac surgery patients in the ICU. J Diabetes Sci Technol. 2015; 9:663–7.
Article
53. Punke MA, Decker C, Wodack K, Reuter DA, Kluge S. Continuous glucose monitoring on the ICU using a subcutaneous sensor. Med Klin Intensivmed Notfmed. 2015; 110:360–3.
Article
54. Ballesteros D, Martinez O, Blancas Gomez-Casero R, Martin Parra C, Lopez Matamala B, Estebanez B, et al. Continuous tissue glucose monitoring correlates with measurement of intermittent capillary glucose in patients with distributive shock. Med Intensiva. 2015; 39:405–11.
Article
55. De Block CE, Gios J, Verheyen N, Manuel-y-Keenoy B, Rogiers P, Jorens PG, et al. Randomized evaluation of glycemic control in the medical intensive care unit using real-time continuous glucose monitoring (REGIMEN Trial). Diabetes Technol Ther. 2015; 17:889–98.
Article
56. Gottschalk A, Welp HA, Leser L, Lanckohr C, Wempe C, Ellger B. Continuous glucose monitoring in patients undergoing extracorporeal ventricular assist therapy. PLoS One. 2016; 11:e0148778.
Article
57. Nohra E, Buckman S, Bochicchio K, Chamieh J, Reese S, Merrill C, et al. Results of a near continuous glucose monitoring technology in surgical intensive care and trauma. Contemp Clin Trials. 2016; 50:1–4.
Article
58. Righy Shinotsuka C, Brasseur A, Fagnoul D, So T, Vincent JL, Preiser JC. Manual versus automated moNitoring accuracy of glucosE II (MANAGE II). Crit Care. 2016; 20:380.
Article
59. Wollersheim T, Engelhardt LJ, Pachulla J, Moergeli R, Koch S, Spies C, et al. Accuracy, reliability, feasibility and nurse acceptance of a subcutaneous continuous glucose management system in critically ill patients: a prospective clinical trial. Ann Intensive Care. 2016; 6:70.
Article
60. Schierenbeck F, Franco-Cereceda A, Liska J. Accuracy of 2 different continuous glucose monitoring systems in patients undergoing cardiac surgery. J Diabetes Sci Technol. 2017; 11:108–16.
Article
61. Song IK, Lee JH, Kang JE, Park YH, Kim HS, Kim JT. Continuous glucose monitoring system in the operating room and intensive care unit: any difference according to measurement sites? J Clin Monit Comput. 2017; 31:187–94.
Article
62. Ancona P, Eastwood GM, Lucchetta L, Ekinci EI, Bellomo R, Martensson J. The performance of flash glucose monitoring in critically ill patients with diabetes. Crit Care Resusc. 2017; 19:167–74.
63. Bochicchio GV, Nasraway S, Moore L, Furnary A, Nohra E, Bochicchio K. Results of a multicenter prospective pivotal trial of the first inline continuous glucose monitor in critically ill patients. J Trauma Acute Care Surg. 2017; 82:1049–54.
Article
64. Rijkenberg S, van Steen SC, DeVries JH, van der Voort PHJ. Accuracy and reliability of a subcutaneous continuous glucose monitoring device in critically ill patients. J Clin Monit Comput. 2018; 32:953–64.
Article
65. Nukui S, Akiyama H, Soga K, Takao N, Tsuchihashi Y, Iijima N, et al. Risk of hyperglycemia and hypoglycemia in patients with acute ischemic stroke based on continuous glucose monitoring. J Stroke Cerebrovasc Dis. 2019; 28:104346.
Article
66. Furushima N, Egi M, Obata N, Sato H, Mizobuchi S. Mean amplitude of glycemic excursions in septic patients and its association with outcomes: a prospective observational study using continuous glucose monitoring. J Crit Care. 2021. 63:218–22.
Article
67. Chow KW, Kelly DJ, Gupta R, Miller JD. Use of continuous glucose monitoring to assess parenteral nutrition-induced hyperglycemia in an adult patient with severe COVID-19. JPEN J Parenter Enteral Nutr. 2021; 45:208–11.
Article
68. Garelli F, Rosales N, Fushimi E, Arambarri D, Mendoza L, De Battista H, et al. Remote glucose monitoring platform for multiple simultaneous patients at coronavirus disease 2019 intensive care units: case report including adults and children. Diabetes Technol Ther. 2020. Dec. 18. [Epub]. https://doi.org/10.1089/dia.2020.0556 .
Article
69. Bridges BC, Preissig CM, Maher KO, Rigby MR. Continuous glucose monitors prove highly accurate in critically ill children. Crit Care. 2010; 14:R176.
Article
70. Steil GM, Langer M, Jaeger K, Alexander J, Gaies M, Agus MS. Value of continuous glucose monitoring for minimizing severe hypoglycemia during tight glycemic control. Pediatr Crit Care Med. 2011; 12:643–8.
Article
71. Prabhudesai S, Kanjani A, Bhagat I, Ravikumar KG, Ramachandran B. Accuracy of a real-time continuous glucose monitoring system in children with septic shock: a pilot study. Indian J Crit Care Med. 2015; 19:642–7.
Article
72. Kotzapanagiotou E, Tsotridou E, Volakli E, Dimitriadou M, Chochliourou E, Kalamitsou S, et al. Evaluation of continuous flash glucose monitoring in a pediatric ICU setting. J Clin Monit Comput. 2020; 34:843–52.
Article
73. Sopfe J, Vigers T, Pyle L, Giller RH, Forlenza GP. Safety and accuracy of factory-calibrated continuous glucose monitoring in pediatric patients undergoing hematopoietic stem cell transplantation. Diabetes Technol Ther. 2020; 22:727–33.
Article
74. Chesser H, Abdulhussein F, Huang A, Lee JY, Gitelman SE. Continuous glucose monitoring to diagnose hypoglycemia due to late dumping syndrome in children after gastric surgeries. J Endocr Soc. 2021; 5:bvaa197.
Article
75. Tripyla A, Herzig D, Joachim D, Nakas CT, Amiet F, Andreou A, et al. Performance of a factory-calibrated, real-time continuous glucose monitoring system during elective abdominal surgery. Diabetes Obes Metab. 2020; 22:1678–82.
Article
76. Nair BG, Dellinger EP, Flum DR, Rooke GA, Hirsch IB. A pilot study of the feasibility and accuracy of inpatient continuous glucose monitoring. Diabetes Care. 2020; 43:e168–9.
Article
77. Dungan KM, Han W, Miele A, Zeidan T, Weiland K. Determinants of the accuracy of continuous glucose monitoring in non-critically ill patients with heart failure or severe hyperglycemia. J Diabetes Sci Technol. 2012; 6:884–91.
Article
78. Burt MG, Roberts GW, Aguilar-Loza NR, Stranks SN. Brief report: comparison of continuous glucose monitoring and finger-prick blood glucose levels in hospitalized patients administered basal-bolus insulin. Diabetes Technol Ther. 2013; 15:241–5.
Article
79. Gomez AM, Umpierrez GE, Munoz OM, Herrera F, Rubio C, Aschner P, et al. Continuous glucose monitoring versus capillary point-of-care testing for inpatient glycemic control in type 2 diabetes patients hospitalized in the general ward and treated with a basal bolus insulin regimen. J Diabetes Sci Technol. 2015; 10:325–9.
Article
80. Schaupp L, Donsa K, Neubauer KM, Mader JK, Aberer F, Holl B, et al. Taking a closer look: continuous glucose monitoring in non-critically Ill hospitalized patients with type 2 diabetes mellitus under basal-bolus insulin therapy. Diabetes Technol Ther. 2015; 17:611–8.
81. Spanakis EK, Levitt DL, Siddiqui T, Singh LG, Pinault L, Sorkin J, et al. The effect of continuous glucose monitoring in preventing inpatient hypoglycemia in general wards: the glucose telemetry system. J Diabetes Sci Technol. 2018; 12:20–5.
Article
82. Migdal AL, Spanakis EK, Galindo RJ, Davis G, Singh LG, Satyarengga M, et al. Accuracy and precision of continuous glucose monitoring in hospitalized patients undergoing radiology procedures. J Diabetes Sci Technol. 2020; 14:1135–6.
Article
83. Shehav-Zaltzman G, Segal G, Konvalina N, Tirosh A. Remote glucose monitoring of hospitalized, quarantined patients with diabetes and COVID-19. Diabetes Care. 2020; 43:e75–6.
Article
84. Singh LG, Levitt DL, Satyarengga M, Pinault L, Zhan M, Sorkin JD, et al. Continuous glucose monitoring in general wards for prevention of hypoglycemia: results from the glucose telemetry system pilot study. J Diabetes Sci Technol. 2020; 14:783–90.
Article
85. Reutrakul S, Genco M, Salinas H, Sargis RM, Paul C, Eisenberg Y, et al. Feasibility of inpatient continuous glucose monitoring during the COVID-19 pandemic: early experience. Diabetes Care. 2020; 43:e137–8.
Article
86. Galindo RJ, Migdal AL, Davis GM, Urrutia MA, Albury B, Zambrano C, et al. Comparison of the FreeStyle Libre pro flash continuous glucose monitoring (CGM) system and point-of-care capillary glucose testing in hospitalized patients with type 2 diabetes treated with Basal-Bolus insulin regimen. Diabetes Care. 2020; 43:2730–5.
87. Singh LG, Satyarengga M, Marcano I, Scott WH, Pinault LF, Feng Z, et al. Reducing inpatient hypoglycemia in the general wards using real-time continuous glucose monitoring: the glucose telemetry system, a randomized clinical trial. Diabetes Care. 2020; 43:2736–43.
Article
88. Fortmann AL, Spierling Bagsic SR, Talavera L, Garcia IM, Sandoval H, Hottinger A, et al. Glucose as the fifth vital sign: a randomized controlled trial of continuous glucose monitoring in a non-ICU hospital setting. Diabetes Care. 2020; 43:2873–7.
Article
89. Ushigome E, Yamazaki M, Hamaguchi M, Ito T, Matsubara S, Tsuchido Y, et al. Usefulness and safety of remote continuous glucose monitoring for a severe COVID-19 patient with diabetes. Diabetes Technol Ther. 2021; 23:78–80.
Article
90. Carlson AL, Criego AB, Martens TW, Bergenstal RM. HbA1c: the glucose management indicator, time in range, and standardization of continuous glucose monitoring reports in clinical practice. Endocrinol Metab Clin North Am. 2020; 49:95–107.
91. Kumar RB, Goren ND, Stark DE, Wall DP, Longhurst CA. Automated integration of continuous glucose monitor data in the electronic health record using consumer technology. J Am Med Inform Assoc. 2016; 23:532–7.
Article
92. Espinoza J, Shah P, Raymond J. Integrating continuous glucose monitor data directly into the electronic health record: proof of concept. Diabetes Technol Ther. 2020; 22:570–6.
Article
93. Khatsenko K, Khin Y, Maibach H. Allergic contact dermatitis to components of wearable adhesive health devices. Dermatitis. 2020; 31:283–6.
Article
94. Didyuk O, Econom N, Guardia A, Livingston K, Klueh U. Continuous glucose monitoring devices: past, present, and future focus on the history and evolution of technological innovation. J Diabetes Sci Technol. 2020. Jan. 13. [Epub]. https://doi.org/10.1177/1932296819899394 .
Article
95. Kenda K, Kazic B, Novak E, Mladenic D. Streaming data fusion for the internet of things. Sensors (Basel). 2019; 19:1955.
Article
96. Faintuch J, Faintuch S. Obesity and diabetes: scientific advances and best practice. Cham: Springer International Publishing;2020. Chapter 42:Glucose control in the intensive care unit. p. 579–89.
97. Tang L, Chang SJ, Chen CJ, Liu JT. Non-invasive blood glucose monitoring technology: a review. Sensors (Basel). 2020; 20:6925.
Article
98. Min J, Sempionatto JR, Teymourian H, Wang J, Gao W. Wearable electrochemical biosensors in North America. Biosens Bioelectron. 2021; 172:112750.
Article
99. Ehrhardt N, Hirsch IB. The impact of COVID-19 on CGM Use in the hospital. Diabetes Care. 2020; 43:2628–30.
Article
Full Text Links
  • ENM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr